Contact
searchSearch
HMP Global
Login

March/April 2026

From the Field
Shining a Light on Payer Management in Medical-Benefit Oncology: A Call for Action to Prioritize Patient Care
04/18/2026
Lucio Gordan, MD; Kiana Mehring, MBA, PPMC; David T. Wenk, MD; Josh Eaves; Ryan Ciarrocchi
This study reveals how increasing payer control over oncology treatments is driving delays and administrative burden, undermining evidence-based, physician-led care and timely patient access.
This study reveals how increasing payer control over oncology treatments is driving delays and administrative burden, undermining evidence-based, physician-led care and timely patient access.
This study reveals how...
04/18/2026
Journal of Clinical Pathways
Original Research
NALIRIFOX Compared With FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma: An Overall Survival External Control Arm Study
04/18/2026
Daniel A. King, MD, PhD; Mei Sheng Duh, ScD; Rose Chang, ScD; Louise Yu, MS; Chunyi Xu, MS; Eric M. Maiese, PhD; George Kim, MD
This study highlights NALIRIFOX as a potentially more effective first-line treatment than FOLFIRINOX for treatment-naive metastatic pancreatic ductal adenocarcinoma.
This study highlights NALIRIFOX as a potentially more effective first-line treatment than FOLFIRINOX for treatment-naive metastatic pancreatic ductal adenocarcinoma.
This study highlights NALIRIFOX...
04/18/2026
Journal of Clinical Pathways
Letter from the Editor
Progress Under Pressure: Aligning Innovation, Access, and Value in Oncology Care
04/17/2026
Alan J. Balch, PhD, MSc
As innovation accelerates in oncology, Editor-in-Chief Alan Balch, PhD, MSc, discusses how evolving evidence, payer dynamics, and care delivery models are reshaping the path to timely, patient-centered treatment.
As innovation accelerates in oncology, Editor-in-Chief Alan Balch, PhD, MSc, discusses how evolving evidence, payer dynamics, and care delivery models are reshaping the path to timely, patient-centered treatment.
As innovation accelerates in...
04/17/2026
Journal of Clinical Pathways
Transformative Business Trends
Navigating the Turns: Steering Health Benefits Through Economic and Clinical Transitions
04/16/2026
F. Randy Vogenberg, PhD, FASHP
As double-digit cost increases collide with economic uncertainty, employers are turning to data-driven clinical pathways to better control spending, improve outcomes, and shape more targeted health benefits for 2027.
As double-digit cost increases collide with economic uncertainty, employers are turning to data-driven clinical pathways to better control spending, improve outcomes, and shape more targeted health benefits for 2027.
As double-digit cost increases...
04/16/2026
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Episode 5: PBMs, Part D, and Pathways—Who Really Controls Oncology Access?
04/08/2026
Gordon Kuntz; Bryan Loy, MD, MBA
In this episode of The Pathways Guys Podcast, our hosts cover Medicare Part D formularies in oncology, explaining how pharmacy benefit managers design drug coverage and how this impacts oncology market access, reimbursement, and patient care.
In this episode of The Pathways Guys Podcast, our hosts cover Medicare Part D formularies in oncology, explaining how pharmacy benefit managers design drug coverage and how this impacts oncology market access, reimbursement, and patient care.
In this episode of The Pathways...
04/08/2026
Journal of Clinical Pathways

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

April 2026 Volume 12 Issue 2

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use